Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 65,523	$ 107,858
Restricted cash	490	490
Marketable securities	152,170	215,464
Accounts receivable	7,280	0
Other receivables	6,815	4,346
Inventory	346	0
Derivative asset	160	0
Prepaid expenses and other current assets	3,268	3,341
Total current assets	236,052	331,499
Property, plant, and equipment, net	220,807	154,183
Operating lease right-of-use asset	2,479	2,779
Intangible assets, net	142	160
Other long-term assets	17,224	5,079
Total assets	476,704	493,700
Current liabilities
Accounts payable	6,755	10,384
Accrued expenses	4,355	8,414
Operating lease liability, current	611	619
Other liabilities, current	397	51
Derivative liability	9	344
Total current liabilities	12,127	19,812
Earnout liability	22,386	42,533
Canadian Government Research and Development Program liability	7,345	7,185
Assumed common stock warrants liability	26,249	30,872
Notes payable	5,189	5,847
Operating lease liability	1,962	2,249
Other liabilities, long-term	8,943	8,297
Total liabilities	84,201	116,795
Commitments and contingencies (See Note 19)
STOCKHOLDERS’ EQUITY
Preferred stock, $0.0001 par value, 10,000,000 shares authorized; no shares issued and outstanding as of June 30, 2023 and December 31, 2022	0	0
Common stock, $0.0001 par value, 1,000,000,000 shares authorized; 143,498,724 and 143,034,225, issued and outstanding as of June 30, 2023 and December 31, 2022, respectively (including 4,500,000 Sponsor Vesting Shares)	14	14
Additional paid-in capital	377,059	371,072
Retained earnings	25,077	21,772
Accumulated other comprehensive loss	(9,647)	(15,953)
Total stockholders’ equity	392,503	376,905
Total liabilities and stockholders’ equity	$ 476,704	$ 493,700